NFKB1 and ovarian carcinoma: The NF-κB signaling pathway has been depicted to play an oncogenic role in ovarian cancer, in consideration of its demonstrated anti-apoptotic and immunomodulatory properties, thus presenting an attractive potential therapeutic target for treating ovarian cancer (24).